HELX Holdings Information

HELX is an equity ETF with a total of 71 individual holdings. The top holdings are Guardant Health stock at 9.38%, Natera at 8.39%, Krystal Biotech at 5.57%, Adaptive Biotechnologies at 4.53%, and Ligand Pharmaceuticals at 4.24%.

Total Holdings

Top 10 Percentage

48.45%

Asset Class

Equity

ETF Category

Health

Assets

32.40M

PE Ratio

33.05

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GH	Guardant Health, Inc.	9.38%	18,136
2	NTRA	Natera, Inc.	8.39%	8,227
3	KRYS	Krystal Biotech, Inc.	5.57%	5,096
4	ADPT	Adaptive Biotechnologies Corporation	4.53%	55,667
5	LGND	Ligand Pharmaceuticals Incorporated	4.24%	4,376
6	BBIO	BridgeBio Pharma, Inc.	3.70%	14,066
7	TWST	Twist Bioscience Corporation	3.54%	9,069
8	UTHR	United Therapeutics Corporation	3.19%	1,938
9	TVTX	Travere Therapeutics, Inc.	2.96%	14,486
10	LLY	Eli Lilly and Company	2.96%	762
11	VRTX	Vertex Pharmaceuticals Incorporated	2.75%	1,655
12	KRX: 207940	Samsung Biologics Co.,Ltd.	2.70%	752
13	CTVA	Corteva, Inc.	2.47%	9,800
14	MEDP	Medpace Holdings, Inc.	2.31%	1,213
15	REGN	Regeneron Pharmaceuticals, Inc.	2.28%	862
16	LON: AZN	AstraZeneca PLC	2.19%	4,263
17	NBIX	Neurocrine Biosciences, Inc.	1.65%	3,276
18	RGEN	Repligen Corporation	1.56%	2,837
19	CRL	Charles River Laboratories International, Inc.	1.54%	1,667
20	TEM	Tempus AI, Inc.	1.50%	8,774
21	EBR: ARGX	argenx SE	1.47%	529
22	PRAX	Praxis Precision Medicines, Inc.	1.38%	1,147
23	CDNA	CareDx, Inc.	1.28%	8,571
24	VCYT	Veracyte, Inc.	1.27%	9,340
25	PTCT	PTC Therapeutics, Inc.	1.27%	5,366

Showing 25 of 71 holdings

Subscribe to see the full list

Activate Now

As of Aug 17, 2026